Heart failure affects 4% of the US population, yet treatment options are primarily symptomatic, including blood thinners, assistive devices and heart transplant. Patients today face a 50% 5-year survival rate upon diagnosis.
It’s time to change that.
Our approach is to engineer human cardiac organoids that function similarly to adult human heart tissue, enabling us to directly target therapeutics to the heart. We aim to address the root cause of heart failure and restore heart function.
Company Details
- Employees
- 7
- Address
- San Francisco, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.dynomics.com
- Keywords
- Brisbane.
- HQ
- San Francisco, CA
Dynomics Questions
Dynomics's website is http://www.dynomics.com
Dynomics's LinkedIn profile is https://www.linkedin.com/company/dynomicsinc
Dynomics has
7 employees.
View email and phone details for 7
employees at Dynomics.
Dynomics's industry is
Biotechnology Research
Dynomics's top competitors are
Colin Green,
Evren Technologies,
Boost Vc,
Dynomic,
Kimia,
Barcelona Liver Bioservices,
Syntropi,
Anff Queensland,
I'm Your Ally,
Qimr Berghofer.
Dynomics's categories are Biotechnology Research
